{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:33:09Z","timestamp":1791181989346,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.leukres.2004.05.003","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T16:51:31Z","timestamp":1103215891000},"page":"131-134","source":"Crossref","is-referenced-by-count":26,"title":["Successful treatment of systemic mastocytosis with high-dose interferon-alfa: long-term follow-up of a case"],"prefix":"10.1016","volume":"29","author":[{"given":"Joseph H.","family":"Butterfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayalew","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Kozuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2004.05.003_BIB1","first-page":"385","article-title":"Biology, classification and treatment of human mastocytosis","volume":"108","author":"Valent","year":"1996","journal-title":"Wien. Klin. Wochenschr"},{"key":"10.1016\/j.leukres.2004.05.003_BIB2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk. Res"},{"key":"10.1016\/j.leukres.2004.05.003_BIB3","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1056\/NEJM198312293092603","article-title":"Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites","volume":"309","author":"Keyzer","year":"1983","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.leukres.2004.05.003_BIB4","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1056\/NEJM198012113032405","article-title":"Increased production of prostaglandin D2 in patients with systemic mastocytosis","volume":"303","author":"Roberts","year":"1980","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.leukres.2004.05.003_BIB5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/339150a0","article-title":"Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation","volume":"339","author":"Wodnar-Filipowicz","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2004.05.003_BIB6","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.4049\/jimmunol.151.6.3261","article-title":"Human mast cells produce IL-8","volume":"151","author":"Moller","year":"1993","journal-title":"J. Immunol"},{"key":"10.1016\/j.leukres.2004.05.003_BIB7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/1523-1747.ep12395649","article-title":"Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1)","volume":"103","author":"Grabbe","year":"1994","journal-title":"J. Invest. Dermatol"},{"key":"10.1016\/j.leukres.2004.05.003_BIB8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1994.tb39789.x","article-title":"Release and inactivation of interleukin-4 by mast cells","volume":"725","author":"Tunon de Lara","year":"1994","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"10.1016\/j.leukres.2004.05.003_BIB9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1749-6632.1996.tb32589.x","article-title":"The mast cell as a source of cytokines in asthma","volume":"796","author":"Bradding","year":"1996","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"10.1016\/j.leukres.2004.05.003_BIB10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0091-6749(98)70140-X","article-title":"Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells","volume":"102","author":"Toru","year":"1998","journal-title":"J. Allergy Clin. Immunol"},{"key":"10.1016\/j.leukres.2004.05.003_BIB11","doi-asserted-by":"crossref","first-page":"769","DOI":"10.7326\/0003-4819-90-5-769","article-title":"Effect of cimetidine on gastric hypersecretion and diarrhea in systemic mastocytosis","volume":"90","author":"Hirschowitz","year":"1979","journal-title":"Ann. Intern. Med"},{"key":"10.1016\/j.leukres.2004.05.003_BIB12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJM197908303010903","article-title":"Oral disodium cromoglycate in the treatment of systemic mastocytosis","volume":"301","author":"Soter","year":"1979","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.leukres.2004.05.003_BIB13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0091-6749(84)90172-6","article-title":"Mastocytosis","volume":"74","author":"Lewis","year":"1984","journal-title":"J. Allergy Clin. Immunol"},{"key":"10.1016\/j.leukres.2004.05.003_BIB14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4065\/70.5.481","article-title":"Aspirin idiosyncrasy in systemic mast cell disease: a new look at mediator release during aspirin desensitization","volume":"70","author":"Butterfield","year":"1995","journal-title":"Mayo Clin. Proc"},{"issue":"Suppl. 1","key":"10.1016\/j.leukres.2004.05.003_BIB15","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1007\/BF03354080","article-title":"Histamine metabolism in mastocytosis patients treated with interferon \u03b1-2b","volume":"45","author":"Granerus","year":"1996","journal-title":"Inflamm. Res"},{"key":"10.1016\/j.leukres.2004.05.003_BIB16","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/10428199609054789","article-title":"Treatment of three patients with systemic mastocytosis with interferon alpha-2b","volume":"22","author":"Worobec","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2004.05.003_BIB17","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1046\/j.1365-2141.2002.03944.x","article-title":"Treatment of adult systemic mastocytosis with inferon-\u03b1: results of a multicentre phase II trial on 20 patients","volume":"119","author":"Casassus","year":"2002","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.leukres.2004.05.003_BIB18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM199202273260907","article-title":"Response to inferferon alfa-2b in a patient with systemic mastocytosis","volume":"326","author":"Kluin-Nelemans","year":"1992","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.leukres.2004.05.003_BIB19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2257.1994.tb00423.x","article-title":"Systemic mastocytosis\u2014a case treated with interferon \u03b1 and radiotherapy","volume":"16","author":"Harrison","year":"1994","journal-title":"Clin. Lab. Haematol"},{"key":"10.1016\/j.leukres.2004.05.003_BIB20","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/0190-9622(95)91545-1","article-title":"Systemic mastocytosis associated with chronic myelomonocytic leukemia: clinical features and response to interferon alfa therapy","volume":"32","author":"Petit","year":"1995","journal-title":"J. Am. Acad. Dermatol"},{"key":"10.1016\/j.leukres.2004.05.003_BIB21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2133.1998.02131.x","article-title":"Response of severe systemic mastocytosis to interferon alpha","volume":"138","author":"Butterfield","year":"1998","journal-title":"Br. J. Dermatol"},{"key":"10.1016\/j.leukres.2004.05.003_BIB22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ajh.2830470121","article-title":"Long-term response to interferon-\u03b1 in a patient with systemic mastocytosis and chronic myelomonocytic leukemia (letter to the editor)","volume":"47","author":"Pulik","year":"1994","journal-title":"Am. J. Hematol"},{"key":"10.1016\/j.leukres.2004.05.003_BIB23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2133.1995.tb02499.x","article-title":"Treatment of urticaria pigmentosa using interferon alpha","volume":"133","author":"Kolde","year":"1995","journal-title":"Br. J. Dermatol"},{"key":"10.1016\/j.leukres.2004.05.003_BIB24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2133.1995.tb08689.x","article-title":"Interferon-\u03b1 in combination with corticosteroids improves systemic mast cell disease","volume":"132","author":"Delaporte","year":"1995","journal-title":"Br. J. Dermatol"},{"key":"10.1016\/j.leukres.2004.05.003_BIB25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00663015","article-title":"Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b","volume":"72","author":"Weide","year":"1996","journal-title":"Ann. Hematol"},{"key":"10.1016\/j.leukres.2004.05.003_BIB26","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0190-9622(08)81953-6","article-title":"Interferon treatment of patients with chronic urticaria and mastocytosis","volume":"30","author":"Czarnetzki","year":"1994","journal-title":"J. Am. Acad. Dermatol"},{"key":"10.1016\/j.leukres.2004.05.003_BIB27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000204898","article-title":"Anaphylactic-like syndrome in systemic mastocytosis treated with alpha-2-interferon","volume":"85","author":"Pardini","year":"1991","journal-title":"Acta Haematol"},{"key":"10.1016\/j.leukres.2004.05.003_BIB28","first-page":"72","article-title":"Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant human stem cell factor","volume":"84","author":"Irani","year":"1995","journal-title":"Immunology"},{"key":"10.1016\/j.leukres.2004.05.003_BIB29","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1172\/JCI119336","article-title":"Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems","volume":"99","author":"Finotto","year":"1997","journal-title":"J. Clin. Invest"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212604002176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212604002176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T23:17:53Z","timestamp":1682896673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212604002176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0145212604002176"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2004.05.003","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}